Terms: = Gastric cancer AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
5 results:
1. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].
Lin X; Huang M; Chen J; Zhou X; Zhong Z; Lu W; Huang X; Liu T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1432-1439. PubMed ID: 37712282
[TBL] [Abstract] [Full Text] [Related]
2. Chemical characterization of Brazilian savannah Byrsonima species (muricis) and their impact on genomic instability and chemopreventive effects.
Specian AFL; Tuttis K; Serpeloni JM; Ribeiro DL; Nunes HL; Tangerina MMP; Sannomiya M; Varanda EA; Vilegas W; Cólus IMS
Mutat Res Genet Toxicol Environ Mutagen; 2023 Apr; 887():503586. PubMed ID: 37003647
[TBL] [Abstract] [Full Text] [Related]
3. Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer.
Lin M; Yao W; Xiao Y; Dong Z; Huang W; Zhang F; Zhou X; Liang M
Bioengineered; 2021 Dec; 12(1):6343-6353. PubMed ID: 34506231
[TBL] [Abstract] [Full Text] [Related]
4. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
5. Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.
Rachamalla R; Malamud S; Grossbard ML; Mathew S; Dietrich M; Kozuch P
Anticancer Drugs; 2004 Mar; 15(3):211-7. PubMed ID: 15014353
[TBL] [Abstract] [Full Text] [Related]
